Perihilar cholangiocarcinoma: Current therapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 5, Issue 3

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

426

WORD

307

HTML

3321

Tables (1-5)

275

Sum=4329

Aug 15, 2014 (publication date) through Nov 1, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pathophysiology

ISSN

2150-5330

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastrointest Pathophysiol. Aug 15, 2014; 5(3): 344-354
Published online Aug 15, 2014. doi: 10.4291/wjgp.v5.i3.344

Table 1 Memorial sloan-kettering cancer center classification

Stage	Criteria
T1	Tumor involving biliary confluence ± unilateral extension to second-order biliary radicles.
T2	Tumor involving biliary confluence ± unilateral extension to second-order biliary radicles and ipsilateral portal vein involvement ± ipsilateral hepatic lobar atrophy
T3	Tumor involving biliary confluence + bilateral extension to second-order biliary radicles; or unilateral extension to second-order biliary radicles with contralateral portal vein involvement; or unilateral extension to second-order biliary radicles with contralateral hepatic lobar atrophy; or main or bilateral portal venous involvement

Citation: Zhang W, Yan LN. Perihilar cholangiocarcinoma: Current therapy. World J Gastrointest Pathophysiol 2014; 5(3): 344-354
URL: https://www.wjgnet.com/2150-5330/full/v5/i3/344.htm
DOI: https://dx.doi.org/10.4291/wjgp.v5.i3.344